These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Isolated Mediastinal Myeloid Sarcoma after Tüfekçi Ö; Yılmaz Ş; Erdem M; Baysal B; Ören H Turk J Haematol; 2019 Nov; 36(4):285-286. PubMed ID: 30859798 [No Abstract] [Full Text] [Related]
3. Oesophageal post-therapy myeloid sarcoma masquerading as poorly differentiated adenocarcinoma: a diagnostic pitfall. Karamchandani DM; Go P; Bayerl M; Karamchandani K Histopathology; 2022 Feb; 80(3):604-606. PubMed ID: 34355418 [No Abstract] [Full Text] [Related]
4. Getting away with phase transition: NPM1-mutated bone myeloid sarcoma mimicking Ewing sarcoma. Marra A; Martino G; Ascani S; Martelli MP; Falini B Ann Hematol; 2019 Aug; 98(8):2017-2018. PubMed ID: 30879096 [No Abstract] [Full Text] [Related]
5. Ph-negative isolated myeloid sarcoma with NPM1 gene mutation in adolescent with Ph-positive chronic myeloid leukemia in remission after treatment with allogeneic bone marrow transplantation and imatinib mesylate. Skalska-Sadowska J; Januszkiewicz-Lewandowska D; Derwich K; Pieczonka A; Samborska M; Wachowiak J Pediatr Blood Cancer; 2015 Jun; 62(6):1070-1. PubMed ID: 25631405 [TBL] [Abstract][Full Text] [Related]
6. Positron Emission Tomography-Computed Tomography Imaging of a Patient With Several Myeloid Sarcomas With FLT3-ITD and NPM1 Mutations. von Keudell G; Larson RA J Clin Oncol; 2016 May; 34(13):e123-5. PubMed ID: 24733791 [No Abstract] [Full Text] [Related]
7. A complex mutational profile and a distinct clonal evolution during NPM1 myeloid sarcoma. Fouillet L; Daguenet E; Guyotat D; Campos-Guyotat L; Grange R; Cornillon J; Jalaber E; Lejeune C; Tavernier E; Flandrin-Gresta P Leuk Lymphoma; 2019 Sep; 60(9):2328-2330. PubMed ID: 30707044 [No Abstract] [Full Text] [Related]
8. Successful second allogeneic stem cell transplantation in a patient with T-lymphoblastic leukemia (T-ALL) relapsed as myeloid sarcoma. Matern S; Schmidt E; Hartmann D; Schliemann C; Groth C; Lenz G; Hartmann W; Klapper W; Berdel W; Stelljes M Ann Hematol; 2017 Jul; 96(7):1201-1203. PubMed ID: 28451803 [No Abstract] [Full Text] [Related]
9. Sustained expression of nucleophosmin (NPM1) mutation at late relapse presenting as isolated myeloid sarcoma in a patient with acute myeloid leukemia. Scholl S; Lüftner J; Mügge LO; Schmidt V; Fricke HJ; Höffken K Ann Hematol; 2007 Oct; 86(10):763-5. PubMed ID: 17639390 [No Abstract] [Full Text] [Related]
10. Clinicopathological and molecular features of myeloid sarcoma as initial presentation of therapy-related myeloid neoplasms: a single institution experience. Peker D; Parekh V; Paluri R; Deal T; Borate U; Di Stasi A; Harada S; Arroyo EA; Reddy V Int J Hematol; 2014 Nov; 100(5):457-63. PubMed ID: 25209604 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemistry and molecular analyses in myeloid sarcoma of the breast in a patient with relapse of NPM1-mutated and FLT3-mutated AML after allogeneic stem cell transplantation. Choschzick M; Bacher U; Ayuk F; Lebeau A J Clin Pathol; 2010 Jun; 63(6):558-61. PubMed ID: 20360144 [TBL] [Abstract][Full Text] [Related]
13. A case of acute promyelocytic leukemia presenting with a nonleukemic granulocytic sarcoma of the ovary, with subsequent development of acute myeloid leukemia associated with t(8;21). Wang X; Liu H; Wu Z; Xu X; Chen X; Zhai Z; Sun Z Leuk Res; 2009 Apr; 33(4):580-2. PubMed ID: 18804280 [No Abstract] [Full Text] [Related]
14. Treatment-related acute myeloid leukemia characterized by t(11;20)(p15;q11) and del(9)(q22). Haimi M; Avivi I; Moustafa N; Aboleil O; Gershoni-Baruch R Cancer Genet Cytogenet; 2006 Jun; 167(2):186-8. PubMed ID: 16737924 [No Abstract] [Full Text] [Related]
15. Therapy-related myeloid neoplasm with bone marrow involvement, myelosarcoma, and a t(8;16)(p11.2;p13.3)-a case report. Chakraborty S; Adams J; Nassiri M; Vance GH Cancer Genet; 2014; 207(10-12):511-5. PubMed ID: 25487769 [TBL] [Abstract][Full Text] [Related]
16. Granulocytic sarcoma 12 years following allogeneic marrow transplant for AML. Lipe BC; Cogbill E; Hill J; Meehan K Clin Adv Hematol Oncol; 2011 Dec; 9(12):948-51. PubMed ID: 22252666 [No Abstract] [Full Text] [Related]
17. Acute facial paralysis and otomastoiditis as presenting symptoms of myeloid sarcoma. Howell J; Segel J; Jajosky R; Savage NM; Fields B; Kota V; Mowry S Otol Neurotol; 2015 Apr; 36(4):e104-6. PubMed ID: 25141186 [No Abstract] [Full Text] [Related]